Lassa fever in West Africa
Updated: December 20, 2018
Note:
- Information regarding Lassa fever in Nigeria was updated.
Original publication date: August 21, 2017
Current situation
Lassa fever is a known risk in West Africa. It occurs in Benin, Burkina Faso, Ghana, Guinea, Liberia, Mali, Nigeria, Sierra Leone, Togo and other West African countries.
Nigeria is currently experiencing an outbreak of Lassa fever. Over 550 confirmed cases and over 140 deaths have been reported so far in 2018. Suspected and/or confirmed cases have been reported in 23 of 36 states.
In 2018, the World Health Organization has confirmed cases and/or outbreaks of Lassa fever in:
- Benin
- Ghana
- Liberia
- Nigeria
About Lassa fever
Lassa fever is caused by the Lassa virus. Lassa virus is most commonly spread through the urine and feces of infected rats.
This includes:
- direct contact with rat urine or feces
- touching objects soiled with urine or feces
- exposure of open cuts or sores
- eating contaminated food
- breathing in dust or dirt that is contaminated with the virus (which can happen during cleaning activities like sweeping or dusting)
Those who are most at risk of getting Lassa fever:
- live or work in areas with a risk of Lassa fever and have been exposed to infected rats or their urine and/or feces
- provide care for patients in a community where the illness is present
- are sexual partners of a male who is within 3 months of being infected
Lassa virus can also be spread between humans through direct contact with the blood, tissue, urine, feces or other bodily fluids of a person infected with Lassa fever.
Typically, about 1% of infected people will die from Lassa fever.
There is no vaccine or medication that protects against Lassa fever.
Symptoms
Most people infected with Lassa virus will have mild, or no symptoms. If symptoms occur, they are usually gradual and include:
- fever
- general weakness
- headache
- sore throat
- chest and muscle pain
- nausea and vomiting
- diarrhea
In some instances, the illness can progress to a severe form with symptoms of:
- face and neck swelling
- respiratory distress
- bleeding from the mouth, nose, vagina or gastrointestinal tract
- shock
- seizure
- altered mental state
The disease is especially severe during late pregnancy when maternal death frequently occurs; fetal loss occurs in more than 80% of cases, particularly during the third trimester.
Recommendations for travellers
Consult a health care professional or visit a travel health clinic at least six weeks before you travel.
- Avoid contact with rodents (rats), especially rat urine and feces.
- Store food in rodent-proof containers
- Dispose of garbage far from your living quarters
- Maintain clean living quarters
- Do not eat rats
- Ensure that food is well cooked
- If it is necessary to clean areas contaminated by rat urine or feces, follow proper safety precautions.
- Protect yourself from the spread of germs:
- Wash your hands frequently with soap and water.
- Keep your hands away from your face.
- Do not share eating or drinking utensils.
- Clean surfaces that are frequently touched (for example: doorknobs and counters).
- Avoid close contact with sick people and their body fluids.
- Practice safe sex and use condoms correctly.
- Health care workers should follow strict infection control measures. This includes wearing all necessary personal protective equipment such as masks, gloves, gowns, and face shields when caring for patients with suspected or confirmed Lassa fever.
- Monitor your health
- If you develop symptoms of Lassa fever when you are travelling or after you return, see a health care professional. Tell them where you have been travelling or living.
Registration of Canadians Abroad
Sign up with the Registration of Canadians Abroad service to stay connected with the Government of Canada in case of an emergency abroad or an emergency at home.Related links
Other Resources
- World Health Organization: Lassa fever fact sheet
- World Health Organization: Lassa fever: Disease Outbreak News
Report a problem or mistake on this pageShare this pageDate modified: 2017-04-05